"137-anti-cancer-drugs"

The government has capped trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent, with revised prices taking effect on November 9. The NPPA expects prices to fall by up to 70 per cent and annual patient savings to reach Rs 2,500 crore.